In Africa, where the vast majority of malaria cases and deaths occur in young children, WHO recommends that all acute childhood fevers in areas of high malaria endemicity be treated presumptively with an antimalarial. Therefore, the proportion of young children with fever who received an antimalarial drug represents a relevant survey-based indicator of the coverage of antimalarial treatment among all malaria patients with prompt and effective treatment. Between 1998 and 2004, across 35 national surveys, the median proportion of children under 5 years of age that were treated with an antimalarial drug was 49.6% (range 3.0–68.8%).
|